Opus Genetics (IRD) Other Accumulated Expenses (2019 - 2025)
Opus Genetics (IRD) posted Other Accumulated Expenses of $268,000 for Q3 2025, up 325.4% from $63,000 a year earlier and up 1.1% from the prior quarter.
Opus Genetics (IRD) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
At the end of FY2024, Opus Genetics' Other Accumulated Expenses came in at $606,000, up 753.5% from FY2023.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 132.1% (FY2019 to FY2024).
- In prior years, Opus Genetics' Other Accumulated Expenses was $71,000 in FY2023 (-57.5%), $167,000 in FY2022 (+108.8%), $80,000 in FY2021 (+220.0%) and $25,000 in FY2020 (+177.8%).
- Quarterly Other Accumulated Expenses has run from a low of $8,000 in Q3 2021 to a high of $606,000 in Q4 2024 over five years.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last seven quarters, with growth averaging 220.0% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2022, with growth of 825.0%; the weakest was Q4 2023, with a decline of 57.5%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $265,000 (Q2 2025), $380,000 (Q1 2025) and $606,000 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Opus Genetics | 378.53 Mn | 153.81 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 380,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Sep 30, 2022 | 74,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 26,000.00 |
| Dec 31, 2020 | 25,000.00 |
Opus Genetics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IRD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();